New findings reveal that combining erythropoiesis-stimulating agents with ruxolitinib maintains efficacy in treating ...

Among the 7MM, Japan accounts for the second highest total aplastic anemia drugs market. The Aplastic Anemia Treatment Market ...

Lupus can be debilitating and sometimes deadly for the 3 million people who have it. A treatment called CAR T appears to stop ...

Biomedical scientists have discovered that a genetic mutation associated with Crohn’s disease can worsen iron deficiency and ...

Researchers have found a strong correlation between vascular access status (VAS) and demoralization syndrome (DS) in elderly ...

Panelists discuss how risk stratification, symptom burden, and splenomegaly guide treatment decisions for a 68-year-old woman ...

Brooks Bell and Sarah Beran were diagnosed with colon cancer in their 30s. Their doctors initially thought they hemorrhoids ...

Dr. Joshua K. Sabari and Dr. Daniel V. Araujo provide expert insights into genitourinary cancer updates from ASCO 2025.

Regulatory action was based on data from the Phase III IMforte trial, which showed that Zepzelca plus Tecentriq significantly ...

A new study published in the journal of Diabetes Research and Clinical Practice found that patients with type 1 and type 2 ...

In the neoadjuvant and adjuvant phases of arm C, pembrolizumab will be administered on day 1 and enfortumab vedotin will be administered on days 1 and 8 of each cycle. Enrollment is complete for arm A ...